Current Knowledge and Future Direction of Research on Soy Isoflavones As a Therapeutic Agents

Overview

Journal Pharmacogn Rev

Date 2012 Jan 10

PMID 22228950

Citations 25

Authors

V Kalaiselvan

M Kalaivani

A Vijayakumar

K Sureshkumar

K Venkateskumar

Affiliations

Soon will be listed here.

Abstract

Isoflavones, the most abundant phytoestrogens in Soy beans, are structurally similar to 17beta-estradiol. The antioxidant property of the soy isoflavones, namely, genistein and daidzein is well established in different experimental models and also in clinical studies. The compounds have been found effective in the management of diabetes by acting on peroxisome proliferator-activated receptors. It reduces the risk of coronary heart disease by reducing the level of low-density lipoprotein and triglycerides. Soy isoflavones have the potential in the treatment of osteoporosis to act on osteoclasts further to inhibit tyrosine kinase. Among the soy isoflavones, genistein is the potential compound found effective in the treatment of cancer by acting on androgen receptor further to inhibit tyrosine kinases. In this article, various aspects of the diverse biological activities of soy isoflavones and their potential clinical implications with mechanism of action, especially in the treatment and prevention of diabetes, cardiovascular diseases, cancer, osteoporosis, neuroprotection, and also future area of research on soy isoflavones are reviewed and discussed.

Citing Articles

Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level.

Hakkak R, Korourian S, Li W, Spray B, Twaddle N, Randolph C Front Nutr. 2024; 11:1487859.

PMID: 39529929 PMC: 11551038. DOI: 10.3389/fnut.2024.1487859.

The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease.

Zachos K, Gamboa J, Dewji A, Lee J, Brijbassi S, Andreazza A Front Pharmacol. 2024; 15:1428242.

PMID: 39119601 PMC: 11306032. DOI: 10.3389/fphar.2024.1428242.

Soy Protein Concentrate Diets Inversely Affect LPS-Binding Protein Expression in Colon and Liver, Reduce Liver Inflammation, and Increase Fecal LPS Excretion in Obese Zucker Rats.

Li W, Hakkak R Nutrients. 2024; 16(7).

PMID: 38613016 PMC: 11013665. DOI: 10.3390/nu16070982.

Royal Jelly and Fermented Soy Extracts-A Holistic Approach to Menopausal Symptoms That Increase the Quality of Life in Pre- and Post-menopausal Women: An Observational Study.

Balan A, Moga M, Neculau A, Mitrica M, Rogozea L, Ifteni P Nutrients. 2024; 16(5).

PMID: 38474777 PMC: 10934315. DOI: 10.3390/nu16050649.

The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer.

Pejcic T, Zekovic M, Bumbasirevic U, Kalaba M, Vovk I, Bensa M Antioxidants (Basel). 2023; 12(2).

PMID: 36829927 PMC: 9952119. DOI: 10.3390/antiox12020368.

References

Slavin J . Nutritional benefits of soy protein and soy fiber. J Am Diet Assoc. 1991; 91(7):816-9. View

Potter S, Bakhit R, Weingartner K, Chapman K, Nelson R, Prabhudesai M . Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am J Clin Nutr. 1993; 58(4):501-6. DOI: 10.1093/ajcn/58.4.501. View

Kanazawa T, Osanai T, Zhang X, Uemura T, Yin X, Onodera K . Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. J Nutr. 1995; 125(3 Suppl):639S-646S. DOI: 10.1093/jn/125.3_Suppl.639S. View

Barrett J . The science of soy: what do we really know?. Environ Health Perspect. 2006; 114(6):A352-8. PMC: 1480510. DOI: 10.1289/ehp.114-a352. View

Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N . Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262(12):5592-5. View

Carroll K . Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc. 1991; 91(7):820-7. View

Williams J, Jordan S, Barnes S, Blair H . Tyrosine kinase inhibitor effects on avian osteoclastic acid transport. Am J Clin Nutr. 1998; 68(6 Suppl):1369S-1374S. DOI: 10.1093/ajcn/68.6.1369S. View

Krenn L, Potsch V . An efficient HPLC method for the quantification of isoflavones in soy extracts and soy dietary supplements in routine quality control. Pharmazie. 2006; 61(7):582-5. View

Messina M, Bennink M . Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Baillieres Clin Endocrinol Metab. 1999; 12(4):707-28. DOI: 10.1016/s0950-351x(98)80012-8. View

10.

Merrill R, Capocaccia R, Feuer E, Mariotto A . Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol. 2000; 29(2):197-207. DOI: 10.1093/ije/29.2.197. View

11.

Ishii Y, Tanizawa H . Effects of soyasaponins on lipid peroxidation through the secretion of thyroid hormones. Biol Pharm Bull. 2006; 29(8):1759-63. DOI: 10.1248/bpb.29.1759. View

12.

Cooke G . A review of the animal models used to investigate the health benefits of soy isoflavones. J AOAC Int. 2006; 89(4):1215-27. View

13.

Setchell K, Cassidy A . Dietary isoflavones: biological effects and relevance to human health. J Nutr. 1999; 129(3):758S-767S. DOI: 10.1093/jn/129.3.758S. View

14.

Canalis E, Giustina A, Bilezikian J . Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007; 357(9):905-16. DOI: 10.1056/NEJMra067395. View

15.

Lo F, Mak N, Leung K . Studies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cells. Biomed Pharmacother. 2007; 61(9):591-5. DOI: 10.1016/j.biopha.2007.08.021. View

16.

Willett W, Manson J, Liu S . Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr. 2002; 76(1):274S-80S. DOI: 10.1093/ajcn/76/1.274S. View

17.

Wagner J, Zhang L, Shadoan M, Kavanagh K, Chen H, Tresnasari K . Effects of soy protein and isoflavones on insulin resistance and adiponectin in male monkeys. Metabolism. 2008; 57(7 Suppl 1):S24-31. PMC: 2570347. DOI: 10.1016/j.metabol.2008.04.001. View

18.

Crouse 3rd J, Morgan T, Terry J, Ellis J, Vitolins M, Burke G . A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999; 159(17):2070-6. DOI: 10.1001/archinte.159.17.2070. View

19.

Messina M, Wood C . Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J. 2008; 7:17. PMC: 2443803. DOI: 10.1186/1475-2891-7-17. View

20.

Kulling S, Honig D, Simat T, Metzler M . Oxidative in vitro metabolism of the soy phytoestrogens daidzein and genistein. J Agric Food Chem. 2000; 48(10):4963-72. DOI: 10.1021/jf000524i. View